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Hong Kong experienced two large epidemics of pandemic inﬂuenza
A(H1N1pdm09). We used regression methods to estimate the excess
mortality associated with each epidemic. The ﬁrst epidemic of
H1N1pdm09 peaked in September 2009 and was associated with
2 13 [95% conﬁdence interval (CI):  8 08, 11 82] excess all-cause
deaths per 100 000 population. The second epidemic of
H1N1pdm09 in early 2011 was associated with 4 72 [95% CI:  0 70,
10 50] excess deaths per 100 000 population. More than half of the
estimated excess all-cause deaths were attributable to respiratory
causes in each epidemic. The reasons for substantial impact in the
second wave remain to be clariﬁed.
Keywords Excess mortality, H1N1pdm09, impact, inﬂuenza,
pandemic.
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Introduction
The pandemic inﬂuenza A(H1N1)pdm09 virus (pH1N1
hereafter) has caused substantial morbidity and mortality
during 2009–2010 far greater than the laboratory-conﬁrmed
infections
1 while most studies documenting multiple epi-
demic waves following the 2009–2010 pH1N1 epidemic were
based on laboratory-conﬁrmed cases,
2–5 which could sub-
stantially underestimate the true impact of inﬂuenza. Hong
Kong experienced major epidemics of pH1N1 in 2009–2010
and again in 2011. We examined the patterns in excess
mortality associated with pH1N1 during the two epidemics,
compared with preceding and contemporaneous epidemics
of seasonal inﬂuenza viruses.
Methods
Sources of data
Age-speciﬁc weekly deaths and mid-year population sizes
from 1998 to 2011 were obtained from the Census and
Statistics Department of the Hong Kong Government.
Respiratory deaths were coded as 460-519 (ICD-9) or J00-
J99 (ICD-10). Laboratory-conﬁrmed pH1N1 infections in
2009–2010 were collected by the Hong Kong Hospital
Authority.
6 Weekly surveillance data on inﬂuenza-like
illnesses, inﬂuenza virus and respiratory syncytial virus
(RSV) activity in 1998–2011 were obtained from the Hong
Kong Centre for Health Protection. Meteorological para-
meters were obtained from the Hong Kong Observatory.
Statistical analysis
We applied linear regression models to investigate the
association between weekly all-cause and respiratory mor-
tality rates and inﬂuenza activity.
7–9 Linear models were
chosen to reﬂect the assumption that increases in inﬂuenza
activity would lead to additive increases in mortality.
7 The
model allowed for adjustment for the activity of speciﬁc
inﬂuenza virus types/subtypes and RSV, seasonal variation
associated with meteorological variables and general trends
over calendar time, the ICD code transition in 2001, and the
impact of changes in the local pandemic alert level in April
2009 and May 2010 (Appendix).
The inﬂuenza-associated excess mortality rates were esti-
mated as the difference in the predicted mortality rates from
the ﬁtted model in the presence and absence of inﬂuenza
virus activity for a speciﬁc type or subtype over the duration
of each epidemic period. Based on age-speciﬁc estimates of
excess mortality, we derived the age-standardized excess
mortality risk for the all-age group to allow for comparison
of impact caused by different virus subtypes over the study
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residual errors, 95% conﬁdence intervals for excess mortality
rates were estimated with a bootstrap approach.
7,9 All
statistical analyses were conducted in R version 2.15.1.
Results
In the decade prior to 2009, inﬂuenza epidemics typically
occurred in Hong Kong twice per year, with peaks in activity
in the winter in January–March and in the summer in June–
August.
9 This pattern was disrupted by the pandemic
(Figure 1). In the summer of 2009, an epidemic of seasonal
inﬂuenza A(H3N2) was followed by a larger epidemic of
pH1N1 that peaked in September 2009 and did not
completely fade out until mid-2010. Another epidemic of A
(H3N2) occurred in the summer of 2010, and a second
epidemic of pH1N1 occurred in the winter of 2011 peaking
in February. There was no inﬂuenza epidemic in the summer
of 2011. During the period April 2009 to July 2010,
laboratory-conﬁrmed pH1N1 virus infection was a report-
able condition and there were 9647 hospitalizations and 93
deaths among patients with laboratory-conﬁrmed pH1N1; 60
(65%) of the conﬁrmed deaths occurred in the months
April–December 2009 (Figure 2).
Our model captured the variation in all-cause and respi-
ratory mortality in Hong Kong from 1998 through 2011
(Figure 3). In the ﬁrst epidemic wave from 27 April 2009
through24May2010,theexcessmortalityriskassociatedwith
pH1N1 was 2 13 (95% CI:  8 08, 11 82) and 1 23 (95% CI:
 3 20, 5 48) per 100 000 population from all-cause and
respiratory diseases, respectively (Table 1). During the second
epidemic wave from 10 January through 6 March 2011, the
excess mortality risk of pH1N1 was estimated to be 4 72 (95%
CI:  0 70, 10 50) and 3 94 (95% CI: 1 66, 6 36) per 100 000
population for all-cause and respiratory deaths, respectively,
with the majority in the elderly.
The seasonal inﬂuenza A(H3N2) virus which cocirculated
with pH1N1 in the summer of 2009 was associated with an
excess all-cause mortality risk of 3 54 (95% CI: 0 25, 6 77)
per 100 000 population. In 2010, the same virus was
associated with an excess all-cause mortality risk of 6 15
per 100 000 population. In both epidemics, the estimated
excess deaths from all causes were approximately double the
estimated excess deaths from respiratory causes (Table 1).
The ﬁtted model also permitted estimation of the impact of
seasonal inﬂuenza epidemics from 1998 to 2008. The
estimates were very similar to those previously reported,
with the excess deaths associated with epidemics varying
between 1 9 and 12 8 per 100 000 population, and seasonal A
(H3N2) epidemics having greater impact than seasonal A
(H1N1) and B epidemics.
9
Discussion
A second epidemic of pH1N1 occurred in Hong Kong in
2011 despite the ﬁrst epidemic being associated with
infections of up to 50% of school-age children.
6 High
incidence of infection particularly among children in Hong
Figure 1. Type-/subtype-speciﬁc weekly inﬂuenza virus activity in Hong Kong from 2009 through 2011. Inﬂuenza virus activity was estimated by the
weekly proportion of consultations for inﬂuenza-like illness at sentinel clinics multiplied by the weekly virus detection rate (by type/subtype) in the local
public health laboratory. Shaded areas indicate the four inﬂuenza epidemics that occurred in Hong Kong from the emergence of inﬂuenza A
(H1N1pdm09) virus through to the end of 2011. Epidemic of the seasonal inﬂuenza A(H3N2) virus in 2009 (blue area); Epidemic of inﬂuenza A
(H1N1pdm09) virus epidemic in 2009–2010 (red area); Post-pandemic epidemic of the seasonal inﬂuenza A(H3N2) virus in 2010 (blue area); and
Second epidemic of inﬂuenza A(H1N1pdm09) virus epidemic in 2011 (red area).
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10,11 led to expecta-
tions that there would be no further large epidemics of
pH1N1 unless the virus changed antigenically.
10,12 Our
estimate of pH1N1-associated mortality in Hong Kong was
consistent with estimates from three previous studies based
on deaths up to December 2009.
8,9,13
Following the large epidemic in 2009–2010, the USA and
some European countries recorded further epidemics of
pH1N1 in 2010–2011 while the age distribution of reported
severe cases changed compared with the ﬁrst wave.
2,4,5
Mexico reported a fourth wave in 2011–2012 season with
absence of major pH1N1 epidemics in 2010 and identiﬁed a
similar age shift towards elderly based on laboratory-
conﬁrmed pH1N1 hospitalizations and deaths.
3 However,
laboratory-conﬁrmed data may not fully reﬂect the impact of
pH1N1 epidemics.
1 In our study, we identiﬁed a similar
excess mortality impact of pH1N1 in the second wave in
2011 compared with the ﬁrst wave in 2009 (Table 1), while
previous studies suggested an increase in the overall severity
of pH1N1 during the post-pandemic season in the UK and
Germany.
14,15 It is not yet clear whether age-speciﬁc severity
remained the same across both epidemic waves in Hong
Kong, but serologic data across both periods indicate a
similar or higher cumulative incidence of infection in older
adults and the elderly in the second wave compared with the
ﬁrst wave (Cowling BJ, unpublished data), which was likely
to result from herd immunity and age-speciﬁc contact
patterns of the population given that vaccination coverage
was low in Hong Kong during the pandemic.
16
The transmission dynamics underlying the possible change
in age-speciﬁc impact remain unclear. It is unlikely that
excess mortality in early 2011 could have been caused by
other respiratory viruses. In Hong Kong, the only epidemic
respiratory virus in February–March 2011 was inﬂuenza.
17
One possible explanation for the change in age-speciﬁc excess
mortality between the two waves of pH1N1 epidemic is that
some form of immunity protected some adults in the ﬁrst
wave, but that immunity had waned before the second wave.
An alternative possible explanation is that there is seasonal
variation in the viability of alternative modes of transmission
with environmental conditions in the winter being most
supportive of aerosol transmission
18 and because we
A
B
Figure 2. Age-speciﬁc monthly numbers of
hospitalizations and deaths of patients with
laboratory-conﬁrmed inﬂuenza A
(H1N1pdm09) virus infections in Hong Kong,
April 2009 through July 10. (A) Hospitalizations
of patients with conﬁrmed inﬂuenza A
(H1N1pdm09). (B) Deaths of patients with
conﬁrmed inﬂuenza A(H1N1pdm09).
Conﬁrmed inﬂuenza A(H1N1pdm09) virus
infection was a reportable condition between
April 2009 and July 2010. Data on laboratory-
conﬁrmed inﬂuenza A(H1N1pdm09) virus
infections were extracted from the e-ﬂu
electronic database collated by the Hospital
Authority. The changes in age pattern after the
peak of the ﬁrst wave of inﬂuenza A
(H1N1pdm09) in October 2009 could partly be
attributed to recommendations for the reduced
use of laboratory testing and admission of
suspected cases. Laboratory-conﬁrmed
inﬂuenza A(H1N1pdm09) hospitalizations and
deaths were not available after July 2010.
Pandemic H1N1 excess mortality
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different modes.
19 The second epidemic occurred at a similar
time to winter epidemics in previous years,
9 and environ-
mental conditions are presumably suitable for aerosol
transmission at that time of year. In contrast, in New
Zealand where the ﬁrst wave occurred during the usual
inﬂuenza season in 2009, a second wave in 2010 had lower
impact than the ﬁrst wave.
20 However, this does not explain
why the incidence of laboratory-conﬁrmed cases was low
among adults in Hong Kong in early 2010 when pH1N1
continued to circulate (Figure 2). A ﬁnal possible explana-
tion is a genetic change in the virus associated with increased
transmissibility in adults between the two waves, although
antigenic changes have not been identiﬁed to date.
Our study has a few limitations. First, our ecologic analysis
captured the overall impact of the epidemics but the
regression model that we used could not account for the
underlying transmission dynamics. Second, we did not have
age-speciﬁc surveillance data, and our use of aggregate
surveillance data on inﬂuenza and RSV activity could have
led to biases in estimation of the age-speciﬁc impact of
inﬂuenza for some age groups. Third, apart from RSV, we did
not include laboratory information on the circulation of other
respiratory viruses in the community, which might also affect
inﬂuenza activity through virus interference, and could be
associated with mortality rates. Fourth, the lack of statistical
signiﬁcance for some estimates of age-speciﬁc excess mortal-
ity does not imply that excess mortality did not occur, but
may merely reﬂect the low number of deaths attributable to
the virus in Hong Kong with a total population of approx-
imately 7 million people. Finally, we did not examine other
causes or groups of causes of death, which could provide
further insights into the impact of inﬂuenza epidemics.
In conclusion, we identiﬁed the increased mortality impact
of the second epidemic of pH1N1 that was similar to the
impact of seasonal inﬂuenza A(H1N1) epidemics in the
preceding decade.
9 The transmission dynamics underlying a
second wave of pH1N1 with substantial impact remain to be
clariﬁed.
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Table 1. Excess all-cause and respiratory mortality risks (with 95% conﬁdence intervals), per 100 000 population associated with epidemics of
seasonal inﬂuenza A(H3N2) virus and inﬂuenza A(H1N1pdm09) virus overall and by age, in Hong Kong, 2009–2011
Age
A(sH3N2)
April–November 2009
A(H1N1pdm09)
April 2009–May 2010
A(sH3N2)
July–October 2010
A(H1N1pdm09)
January–March 2011
Risk (95% CI) Risk (95% CI) Risk (95% CI) Risk (95% CI)
All-cause
0–64 0 07 ( 0 98, 1 15)  0 23 ( 3 20, 2 91) 0 11 ( 0 74, 1 01) 0 43 ( 1 24, 2 50)
65+ 26 96 (1 80, 51 24) 18 05 ( 57 29, 94 56) 46 89 (24 28, 67 73) 33 7(  8 05, 76 87)
All ages 3 54 (0 25, 6 77) 2 13 ( 8 08, 11 82) 6 15 (3 25, 8 95) 4 72 ( 0 70, 10 50)
Respiratory
0–64 0 09 ( 0 25, 0 40) 0 05 ( 0 77, 1 11) 0 15 ( 0 15, 0 41) 0 57 (0 06, 1 15)
65+ 12 19 ( 0 91, 22 85) 9 18 ( 24 12, 43 25) 21 21 (11 07, 30 32) 26 66 (8 66, 45 16)
All ages 1 65 (0 18, 3 00) 1 23 ( 3 20, 5 48) 2 87 (1 52, 4 00) 3 94 (1 66, 6 36)
A(sH3N2), seasonal inﬂuenza A/Perth/16/2009(H3N2)-like strain; A(H1N1pdm09), pandemic inﬂuenza A/California/7/2009(H1N1)-like strain.
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Appendix
Sentinel surveillance system
The sentinel surveillance system for inﬂuenza was established
in Hong Kong in 1990s. During the study period, the sentinel
sites in the system included all government-sponsored public
general outpatient clinics (which have below 10% of the
market share for outpatient care in Hong Kong) and around
50–60 private general practitioners. The number of outpa-
tient consultations and the proportion of consultations due
to inﬂuenza-like illness were reported to the Centre for
Health Protection of the Department of Health by each
sentinel on a weekly basis.
Virus activity surveillance is another component of the
sentinel surveillance system in Hong Kong. Specimens
collected from sentinel locations were sent to the Public
Health Services Laboratory for the purpose of surveillance.
The clinicians who collected the specimen from the patient
would not be notiﬁed of the result of laboratory testing. It is
therefore less likely that the clinician would selectively choose
patients for sample collection. The laboratory data reported
by the Public Health Services Laboratory also include
laboratory test results on inpatients admitted to local
hospitals and occasional outpatients, and these are not
distinguished in the data.
In this study, we used proxies representing virus activities
of inﬂuenza virus and RSV. The proxy for weekly inﬂuenza
activity was measured as the product of the weekly propor-
tion of specimens collected in the sentinel surveillance system
tested positive for a speciﬁc virus type/subtype and the
weekly proportion of outpatient consultations due to inﬂu-
enza-like illness. In a previous study, we used data collected
during the 2009 inﬂuenza pandemic and demonstrated that
this proxy provides a good indication of incidence of
H1N1pdm09 virus infections in the community (Wong
et al. 2013 AJE). For RSV activity, we used the weekly
proportion of specimens collected in the sentinel surveillance
system tested positive for RSV as the proxy, which was
suggested to be a better proxy in another study (E. Goldstein,
pers. comm.).
Statistical model
We examined inﬂuenza-attributable excess mortality associ-
ated with all-causes, cardiovascular diseases (ICD-9: 390-459;
ICD-10: I00-I99) and respiratory diseases (ICD-9: 460-519;
ICD-10: J00-J99). A linear regression model was used to
estimate the association between the weekly death rates and
all the covariates according to the following regression
equation:
EðMiÞ¼b1   sH1i 1 þ b2   sH3i 1 þ b3   pH1i 1   Pi 1
þ b4   Bi 1 þ b5   RSVi 1 þ b6   nsðTi 1; dfTÞ
þ b7   nsðHi 1; dfHÞþb8   nsði; dfWÞþb9   Ci
þ ei
where E(Mi) is the expected mortality rate in week i. b1–b5
denotes the effects on mortality associated with activities of
different inﬂuenza virus subtypes and respiratory syncytial
virus (RSV). sH1i 1, sH3i 1, Bi 1 and pH1i 1 represent the
weekly virus activity of seasonal inﬂuenza A(H1N1), A
(H3N2) and B, and 2009 pandemic inﬂuenza A(H1N1),
measured as the product of the weekly proportion of
specimens (collected by the local surveillance system from
hospitals and outpatient clinics) tested positive with the
speciﬁc virus subtype and the weekly proportion of outpa-
tient consultations due to inﬂuenza-like illness (ILI). The
RSV activity RSVi-1 was measured as the weekly proportion
of specimens tested positive for the virus. Pi 1 is the
pandemic term used in the model allowing for differences in
the number of specimens collected for virus testing by the
local surveillance system during the pandemic and
Wu et al.
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the time period between the date when the Hong Kong
government declared to include inﬂuenza A(H1N1pdm09) as
statutorily notiﬁable disease on 27 April 2009 and the date
when the inﬂuenza response level in Hong Kong was changed
from ‘Emergency’ to ‘Alert’ on 24 May 2010. b6 and b7 are
the effect of temperature and humidity on mortality,
modelled as cubic smooth splines of the trends in the weekly
temperature and absolute humidity Ti 1 and Hi 1, with the
degree of freedom dfT and dfH. b8 is the effect caused by
changes in temporal trends on mortality. b9 refers to the
effect caused by the transition in ICD coding system in Hong
Kong, that is, from ICD-9 (1998–2000) to ICD-10 (2001–
2011). ei is an error term, assumed to follow a normal
distribution with constant variance over time. A 1-week lag
was assumed between the time-varying covariates and
mortality.
Age-standardization of excess mortality
risk
We derived the all-age excess mortality risk from the age-
speciﬁc estimate of excess mortality by direct standardization
using the following equation:
Mj ¼
X n
i¼1
mi;j   Wi=
X n
i¼1
Wi
where Mj is the age-standardized excess mortality risk
associated with a speciﬁc virus during the time period j.
mi,j represents the estimated excess mortality risk for the age
group i in the time period j. The crude excess mortality risk
for each age group was weighted by the age distribution of
population size during April 2009 to March 2011, which
covers the epidemic waves investigated in the study. Wi is the
population weight for the age group i and measured by the
following equation:
Wi ¼
Ni
N
where Ni is the mean population size for the age group i, and
N is the mean of the total population size during the time
period deﬁned for the study.
Pandemic H1N1 excess mortality
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